Serum total antioxidant capacity to discriminate benign from malignant causes of biliary obstruction ( Author's Reply)

0 0

Yıl: 2014 Cilt: 25 Sayı: 5 Sayfa Aralığı: 593 - 593 Metin Dili: İngilizce İndeks Tarihi: 29-07-2022

Öz:

Anahtar Kelime:

Konular: Cerrahi

Belge Türü: Makale Makale Türü: Editöre Mektup Erişim Türü: Erişime Açık

1. Liu X, Zhao J, Zheng R. DNA damage of tumor-associated lymphocytes and total antioxidant capacity in cancerous patients. Mutat Res 2003; 539: 1-8.
2. Erhola M, Nieminen MM, Kellokumpu-Lehtinen P, et al. Effects of surgical removal of lung cancer on total plasma antioxidant capacity in lung cancer patients. J Exp Clin Canc Res 1998; 17: 219-25.
3. Kumaraguruparan R, Subapriya R, Kabalimoorthy J, Nagini S. Antioxidant profile in the circulation of patients with fibroadenoma and adenocarcinoma of the breast. Clin Biochem 2002; 35: 275-9.
4. Su H-X, Hao C-Y, Mi D-H, et al. 8-hydroxy-2-deoxyguanosine of gastric mucosa DNA and the plasma total radical-trapping antioxidative capacity in patients with gastric adenocarcinoma and chronic gastritis. Chin Med J 2001; 114: 42-57.
5. Skrzydlewska E, Stankiewicz A, Sulkowska M, Sulkowski S, Kasacka I. Antioxidant status and lipid peroxidation in colorectal cancer. J Toxicol Environ Health A 2001; 64: 213-22.
6. Sihvo EI, Salminen JT, Rantanen TK, et al. Oxidative stress has a role in malignant transformation in Barretts oesophagus. Int J Cancer 2002; 102: 551-5.

APA	İNCE A (2014). Serum total antioxidant capacity to discriminate benign from malignant causes of biliary obstruction ( Author's Reply). , 593 - 593.
Chicago	İNCE Ali Tüzün Serum total antioxidant capacity to discriminate benign from malignant causes of biliary obstruction ( Author's Reply). (2014): 593 - 593.
MLA	İNCE Ali Tüzün Serum total antioxidant capacity to discriminate benign from malignant causes of biliary obstruction ( Author's Reply). , 2014, ss.593 - 593.
AMA	İNCE A Serum total antioxidant capacity to discriminate benign from malignant causes of biliary obstruction ( Author's Reply). . 2014; 593 - 593.
Vancouver	İNCE A Serum total antioxidant capacity to discriminate benign from malignant causes of biliary obstruction ( Author's Reply). . 2014; 593 - 593.
IEEE	İNCE A "Serum total antioxidant capacity to discriminate benign from malignant causes of biliary obstruction ( Author's Reply)." , ss.593 - 593, 2014.
ISNAD	İNCE, Ali Tüzün. "Serum total antioxidant capacity to discriminate benign from malignant causes of biliary obstruction ( Author's Reply)". (2014), 593-593.

APA	İNCE A (2014). Serum total antioxidant capacity to discriminate benign from malignant causes of biliary obstruction ( Author's Reply). Turkish Journal of Gastroenterology, 25(5), 593 - 593.
Chicago	İNCE Ali Tüzün Serum total antioxidant capacity to discriminate benign from malignant causes of biliary obstruction ( Author's Reply). Turkish Journal of Gastroenterology 25, no.5 (2014): 593 - 593.
MLA	İNCE Ali Tüzün Serum total antioxidant capacity to discriminate benign from malignant causes of biliary obstruction ( Author's Reply). Turkish Journal of Gastroenterology, vol.25, no.5, 2014, ss.593 - 593.
AMA	İNCE A Serum total antioxidant capacity to discriminate benign from malignant causes of biliary obstruction ( Author's Reply). Turkish Journal of Gastroenterology. 2014; 25(5): 593 - 593.
Vancouver	İNCE A Serum total antioxidant capacity to discriminate benign from malignant causes of biliary obstruction ( Author's Reply). Turkish Journal of Gastroenterology. 2014; 25(5): 593 - 593.
IEEE	İNCE A "Serum total antioxidant capacity to discriminate benign from malignant causes of biliary obstruction ( Author's Reply)." Turkish Journal of Gastroenterology, 25, ss.593 - 593, 2014.
ISNAD	İNCE, Ali Tüzün. "Serum total antioxidant capacity to discriminate benign from malignant causes of biliary obstruction ( Author's Reply)". Turkish Journal of Gastroenterology 25/5 (2014), 593-593.